📊 Q3 Earnings are here! Plan ahead with key data on upcoming stock reports - all in 1 placeSee list

Axon CEO sells over $66 million in company stock

Published 10/02/2024, 08:29 PM
AXON
-

Patrick W. Smith, the Chief Executive Officer of Axon Enterprise, Inc. (NASDAQ:AXON), has sold a significant portion of his company stock, according to recent filings with the Securities and Exchange Commission. Over a series of transactions, Smith sold shares totaling over $66 million, with prices ranging from $400.0243 to $405.2216 per share.

The sales were conducted through a pre-arranged Rule 10b5-1 trading plan, which allows insiders of publicly-traded corporations to set up a trading plan for selling stocks they own. This plan enables them to sell shares at a predetermined time to avoid accusations of insider trading.

On September 30, 2024, Smith executed sales of Axon stock that amounted to approximately $31,946,132, with individual share prices ranging between $400.0243 and $402.5968. The following day, he continued to sell shares worth around $34,395,299, with the price per share ranging from $402.5968 to $405.2216. These transactions reflect the weighted average sales price within the given ranges.

In addition to the sales, Smith also acquired shares through option exercises, which are reported separately and are not included in the total sale value. The total value for these transactions was $68,183,169, with prices per share ranging from $399.22 to $404.51.

Axon Enterprise, Inc., formerly known as Taser International, is a Scottsdale, Arizona-based company specializing in law enforcement technology, including electrical weapons and body cameras. The latest transactions by the CEO have been made public through the mandatory reporting of insider transactions to the SEC.

Investors often monitor insider buying and selling as it can provide insights into a company's financial health and executive confidence. However, it is essential to note that insider transactions can be subject to various motivations and do not necessarily signal a company's future performance.

For further details on the CEO's transactions, interested parties can access the full SEC filings.

In other recent news, Axon Enterprise has been making significant strides in its business, as highlighted by its record-breaking second quarter. Revenue for the period exceeded $500 million, with new business bookings surpassing $1 billion. This robust growth was driven primarily by new products, TASER 10 and Axon Body 4, and a shift in revenue mix, with software and services now accounting for 39% of total revenue.

Baird, a financial services firm, has maintained its Outperform rating on Axon while raising the stock's price target from $360 to $400. This decision reflects the firm's confidence in Axon's continued expansion and innovation, particularly in artificial intelligence capabilities and drone technology.

Axon's future contracted revenue stands at approximately $7.4 billion, and full-year revenue guidance has been raised to between $2 billion and $2.05 billion. The company's adjusted EBITDA reached $123 million, with a margin of 24.5% for the quarter.

Despite these positive developments, Axon executives have expressed cautiousness regarding potential economic downturns. However, they also highlighted the fastest growth in their Cloud and Services segment at 47% year-over-year, and an increase in Annual Recurring Revenue (ARR) to $850 million, a 44% increase year-over-year. These are among the recent developments in Axon's business.

InvestingPro Insights

To provide additional context to Patrick W. Smith's recent stock sales, let's examine some key financial metrics and insights from InvestingPro for Axon Enterprise, Inc. (NASDAQ:AXON).

Axon's market capitalization stands at an impressive $30.56 billion, reflecting its significant presence in the law enforcement technology sector. The company's revenue growth has been robust, with a 32.59% increase over the last twelve months as of Q2 2024, reaching $1.81 billion. This strong performance aligns with an InvestingPro Tip indicating that analysts anticipate sales growth in the current year.

The company's gross profit margin is particularly noteworthy at 59.81%, which InvestingPro highlights as an "impressive gross profit margin." This metric suggests Axon's ability to maintain pricing power and control costs effectively, which is crucial in the technology sector.

Interestingly, while Axon's P/E ratio stands at 104.46, an InvestingPro Tip notes that the company is "trading at a low P/E ratio relative to near-term earnings growth." This could indicate potential undervaluation considering the company's growth prospects. Additionally, Axon holds more cash than debt on its balance sheet, which provides financial flexibility and may contribute to investor confidence.

The stock's performance has been remarkable, with a one-year price total return of 110.62% as of the latest data. This aligns with another InvestingPro Tip highlighting Axon's "high return over the last year." The stock is currently trading near its 52-week high, with the price at 99.63% of its peak.

For investors seeking a more comprehensive analysis, InvestingPro offers 22 additional tips for Axon Enterprise, providing a deeper understanding of the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.